Lv62
2120 积分 2022-06-08 加入
Abstract 3025: Optimization of therapeutic index of SGR-3515, a first-in-class Wee1/Myt1 inhibitor through intermittent dosing for monotherapy and combination with chemotherapy in xenograft tumor models
21小时前
已关闭
147 (PB135): Discovery of SGR-3515, a first-in-class Wee1/Myt1 inhibitor with differentiated pharmacological properties in xenograft tumor models
22小时前
已完结
Myt1 kinase inhibitors - Insight into structural features, offering potential frameworks
6天前
已完结
Discovery of Potent OTUB1/USP8 Dual Inhibitors Targeting Proteostasis in Non-Small-Cell Lung Cancer
8天前
已完结
Identification of novel class inhibitors of NSD3 methyltransferase showing a unique, bivalent binding mode in the SET domain
9天前
已完结
Bleeding to death in a big city: An analysis of all trauma deaths from hemorrhage in a metropolitan area during 1 year
9天前
已完结
NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific Functions
10天前
已完结
An analysis of prehospital deaths
12天前
已完结
Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation
21天前
已完结
C-type natriuretic peptide/guanylate cyclase B system in ATDC5 cells, a chondrogenic cell line
27天前
已完结
皖公网安备34019202002308
